**Matt Cox to Participate in London Marathon Amid Fight Against Motor Neuron Disease**
:max_bytes(150000):strip_icc():format(jpeg)/matt-cox-042426-3-ebd75d882a4641a68f46b3ca09c83ffe.jpg)
Matt Cox, a dedicated runner and television executive, is gearing up to make a poignant statement at the London Marathon, where he will be pushed in a wheelchair by his family. Diagnosed with motor neuron disease (MND) last year, Cox aims to both raise awareness about the condition and garner vital funds for the MND Association.

The 2024 marathon holds personal significance for Cox, who first detected symptoms of MND while on holiday in the United States. “During a lengthy walk at the airport, I realised my feet weren’t behaving as they should. It felt as if I was using my shins to move them,” he recounted during an interview on ITV’s *This Morning*. Initially attributing his difficulties to a lack of proper stretching, he later became increasingly concerned as symptoms persisted.

His turning point came when a friend noticed something was amiss during a dog walk, prompting him to seek medical advice. After a series of assessments, he was diagnosed with MND in the summer of 2025. MND encompasses a variety of neurological disorders that progressively damage the motor neurons in the brain and spinal cord, responsible for controlling vital movements such as walking, speaking, and even breathing. Among these disorders, amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s disease, is the most prevalent.
On receiving his diagnosis, Cox felt bewildered. “Initially, I didn’t fully understand what it was, or even that it was synonymous with ALS. I remember the ice bucket challenges from a few years ago but hadn’t connected the dots,” he shared. His experience reflects a broader need for greater awareness of MNDs, particularly within the UK.
Cox has been vocal about the limited treatment options available for those afflicted with MND, emphasising the financial burden it presents. “MND is an incredibly expensive disease to manage, and the available options are quite limited. I’ve myself struggled with side effects from the one drug that the NHS covers, which is known to prolong life,” he explained. His concern extends to future patients, as he questions, “Who will fill the gaps in care for those who come after me?”
Thanks to a strong support system comprising family and friends, Cox has been able to navigate the challenges presented by his condition. However, he poignantly acknowledges the struggles faced by others who do not have that same network. “I know many individuals contend with this diagnosis in isolation, often without adequate support or treatment options.”
This deep-rooted concern for others is what drives Cox to participate in the upcoming marathon. Scheduled for April 26, 2025, his family will take turns pushing him through the iconic course, embodying the strength of familial bonds in adversity. “My brother Tomos, sister Natalie, and cousin Stewart will each take on this role, alongside my other brother, also named Tom. They all provide me with daily support and, in return, I seek to inspire them,” he said.
A GoFundMe page created in advance of the event reflects this familial spirit. As part of the fundraising effort, Cox has expressed a heartfelt desire to walk the final mile of the marathon on his own feet, if his condition permits. “If I’m feeling up to it on the day, I’d love to walk the final stretch and push one of my family members across the finish line,” he remarked.
Cox’s participation in the London Marathon serves not only as a personal challenge but also as an opportunity to raise awareness and much-needed funds for the MND Association. His story highlights the importance of increased funding for research and better support systems for those affected by motor neuron diseases across the UK.
As Matt Cox prepares for this emotional journey, both he and his family exemplify resilience. Their collective efforts resonate with many, poised to inspire others navigating similar paths through adversity.
